Module 10: Biomolecules

Enzyme Characteristics and Mechanisms

  • Catalytic Nature: Enzymes are biological catalysts composed of proteins that accelerate chemical reactions by lowering activation energy without being consumed, increasing rates by up to 102010^{20} times under physiological conditions.

  • Efficiency Example: Carbonic anhydrase catalyzes CO2+H2O→H2CO3\text{CO}_2 + \text{H}_2\text{O} \rightarrow \text{H}_2\text{CO}_3 to generate 36 million36\text{ million} molecules per minute, preventing toxic CO2\text{CO}_2 accumulation.

  • Catalytic Specificity:

    • Absolute specificity: Catalyzes only one reaction of a single substance (e.g., urease hydrolyzing the amide bond of urea).

    • Relative specificity: Catalyzes reactions of structurally related substances (e.g., proteases hydrolyzing proteins).

    • Stereochemical specificity: Catalyzes reactions of only one specific 3D stereoisomer (e.g., D-amino acid oxidase will not react with L-amino acids).

  • Enzyme Regulation: Cells regulate chemical activity by selectively synthesizing only the specific enzymes needed for their designated function.

  • Nomenclature:

    • Composition-based: End in "-in" (e.g., pepsin, trypsin).

    • International Enzyme Commission (IEC): Systematic names describing substrate, functional group, and reaction type across six classes (e.g., urea amidohydrolase).

    • Common names: Substrate root plus "-ase" (e.g., urease, alcohol dehydrogenase).

  • Models of Action:

    • Lock-and-key model: The active site is a rigid structure matching the exact complementary shape of the substrate.

    • Induced-fit model: The active site is conformationally flexible and adjusts its shape to envelope the incoming substrate.

  • Enzyme Co-factors:

    • Co-factor: A non-protein helper ion or molecule essential for catalytic activity.

    • Co-enzyme: An organic co-factor.

    • Apoenzyme: The inactive, non-functional protein portion remaining after co-factors or co-enzymes are removed.

Induced-fit model showing enzyme conformational change

Factors Regulating Enzyme Activity and Inhibition

  • Enzyme Concentration: Direct linear increase in reaction rate with increasing enzyme concentration, assuming excess substrate.

  • Substrate Concentration: Reaction rate increases until all enzyme active sites become saturated, at which point the rate remains constant.

  • pH Influence: Enzymes operate maximally around physiological pH (∼7\sim 7); deviations lead to denaturation, though specialized enzymes operate in extremes (e.g., stomach enzymes at ∼pH 1\sim \text{pH } 1).

  • Temperature Influence: Optimum activity occurs around physiological temperature (37 ∘C37\,^\circ\text{C}); denaturation occurs at extreme cold (0 ∘C0\,^\circ\text{C}) or heat (60 ∘C60\,^\circ\text{C} and above).

  • Irreversible Inhibition: Permanent inactivation through covalent binding to essential functional groups:

    • CN−\text{CN}^- (cyanide) binds iron in cytochrome oxidase, halting cellular respiration.

    • Heavy metal ions (Hg2+\text{Hg}^{2+}, Pb2+\text{Pb}^{2+}) bind cysteine −SH-\text{SH} groups, precipitating the protein.

  • Reversible Inhibition: Temporary regulation that prevents excessive catalysis:

    • Competitive inhibition: Inhibitor possesses a molecular structure similar to the substrate and competes directly for the active site.

    • Non-competitive inhibition: Inhibitor binds an allosteric site away from the active site, inducing a conformational shift that alters the active site shape.

Diagnostic Enzymes in Medicine

  • Diagnostic Principle: Cell damage or lysis releases tissue-specific intracellular enzymes into bodily fluids above baseline replacement levels, allowing diagnosis via blood serum assays.

  • Serum Assays and Indications:

    • Alanine aminotransferase (ALT): Serum; Hepatitis.

    • Acid phosphatase: Serum; Prostate cancer.

    • Alkaline phosphatase (ALP): Serum; Liver or bone disease.

    • Amylase: Serum; Pancreatic disease.

    • Aspartate aminotransferase (AST): Serum, Cerebrospinal fluid; Heart attack or hepatitis.

    • Lactate dehydrogenase (LDH): Serum; Heart attack.

    • Creatine phosphokinase (CK): Serum; Heart attack.

    • Phosphohexose isomerase (PHI): Serum; Heart attack.

Nucleic Acid Components and DNA Structure

  • Nucleotide Subunits: Monomers comprising a heterocyclic basic amine, a monosaccharide, and a phosphate group.

  • Nitrogenous Bases:

    • Pyrimidines: Single-ring amines consisting of Cytosine (C, both DNA and RNA), Thymine (T, DNA only), and Uracil (U, RNA only).

    • Purines: Fused double-ring amines consisting of Adenine (A) and Guanine (G) in both DNA and RNA.

  • Monosaccharide Components: β\beta-configuration pentoses:

    • D-deoxyribose in DNA (lacks an oxygen at carbon 2′2').

    • D-ribose in RNA.

  • Phosphate Group: Derived from phosphoric acid (H3PO4\text{H}_3\text{PO}_4 or HPO42−\text{HPO}_4^{2-} at pH 7); links monosaccharides via phosphate ester bonds, while bases attach via N-glycosidic bonds.

  • Primary Structure: Unbranched polymer of 1 to 100 million1\text{ to }100\text{ million} nucleotides linked along an alternating phosphate-monosaccharide backbone; sequences are read from 5′5' to 3′3'.

  • Secondary Structure: Antiparallel right-handed double helix where the sugar-phosphate backbone faces outward and heterocyclic bases orient inward.

  • Complementary Base Pairing:

    • Adenine pairs with Thymine (A=T\text{A}=\text{T}) via two hydrogen bonds (O−H\text{O}-\text{H} and H−N\text{H}-\text{N}).

    • Guanine pairs with Cytosine (G≡C\text{G}\equiv\text{C}) via three hydrogen bonds (two O−H\text{O}-\text{H} and one H−N\text{H}-\text{N}).

Hydrogen bonding between thymine-adenine and cytosine-guanine base pairs

DNA Replication

  • Semiconservative Mechanism: Each newly formed double helix consists of one original parental strand and one newly synthesized daughter strand.

  • Step 1 (Unwinding): Helicase unwinds the double helix, creating a replication fork to expose single-stranded templates.

  • Step 2 (Synthesis): Complementary deoxyribonucleotides are added in the 5′→3′5' \rightarrow 3' direction:

    • Leading strand: Synthesized continuously toward the advancing replication fork.

    • Lagging strand: Synthesized discontinuously away from the replication fork as Okazaki fragments, which are subsequently joined.

  • Replication Fidelity and Mutation: Replicative errors occur at an average rate of 1 in 101010^{10} base pairs; mutations in the genetic code can produce beneficial, neutral, or non-functional protein products.

RNA and Protein Synthesis

  • RNA Distinctions: Single-stranded nucleic acid containing D-ribose and Uracil (instead of Thymine); located within the nucleus, cytoplasm, and ribosomes.

  • Classes of RNA:

    • Messenger RNA (mRNA): Short-lived transcript that carries genetic information from nuclear DNA to ribosomes.

    • Ribosomal RNA (rRNA): Structural and catalytic component making up approximately 65%65\% of ribosomes.

    • Transfer RNA (tRNA): Transports specific amino acids from the cytoplasm to the ribosome using complementary anticodons.

  • Genetic Code: Triplet nucleotide codons (43=644^3 = 64 permutations):

    • Degenerate coding: Multiple codons code for the same amino acid (e.g., Alanine has 4: GCA, GCC, GCG, GCU; Tryptophan has 1: UGG).

    • Nonsense (Stop) codons: UAG, UAA, and UGA signal the termination of translation.

  • Transcription: RNA polymerase opens the DNA at the target gene site; ribonucleotides assemble along the DNA template to synthesize a complementary mRNA strand (5′→3′5' \rightarrow 3'), after which DNA rewinds.

  • Translation Stages:

    • Initiation: Initiation factors recruit mRNA, the ribosomal subunits, and initiator tRNA.

    • Elongation: Incoming tRNA enters the aminoacyl (A) site; a peptide bond forms between the amino acid and the growing chain held at the peptidyl (P) site; the empty tRNA is ejected as the ribosome translocates.

    • Termination: Encountering a stop codon triggers release factors to sever the completed polypeptide from the tRNA, disassembling the complex.

Elongation phase of translation on the ribosome

Practice Exam Questions and Base Pairing Solutions

  • Worked Example 1:

    • Original sequence (5′→3′5' \rightarrow 3'): CCAT

    • Complementary strand (3′→5′3' \rightarrow 5'): GGTA

    • Conventional representation (5′→3′5' \rightarrow 3'): ATGG

  • Worked Example 2:

    • Original sequence (5′→3′5' \rightarrow 3'): TGTAATC

    • Complementary strand (3′→5′3' \rightarrow 5'): ACATTAG

    • Conventional representation (5′→3′5' \rightarrow 3'): GATTACA

  • Core Concept Review Topics:

    • Contrast the active site flexibility of the lock-and-key model with that of the induced-fit model.

    • Define the biological distinctions among an apoenzyme, a co-factor, and a co-enzyme.

    • Explain the denaturation of enzyme secondary and tertiary structure caused by extreme temperature and pH.

    • Differentiate the active site blocking of competitive inhibitors from allosteric distortion by non-competitive inhibitors.

    • Contrast primary nucleic acid covalent bonding (phosphodiester and N-glycosidic) with secondary structure stabilization (hydrogen bonding).